Financial Reports of CERo Therapeutics Holdings, Inc. (CERO)

Add CERO to watchlist(s)

You Should Create a Watchlist In The First Place.

Price Over Time

Profile

Company Name

CERo Therapeutics Holdings, Inc.

Symbol

CERO

Currency

USD

Exchange

Nasdaq

Head Quarter

United States, South San Francisco

Sector

Healthcare

Industry

Biotechnology

Website

https://www.cero.bio

ISIN

US71902K1051

CIK

1870404

CUSIP

-

UEI

-

LEI

-

Business Description

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.